Dexcel seeks non-infringement ruling against Takeda’s patents

15-08-2016

Dexcel seeks non-infringement ruling against Takeda’s patents

garajstock / Shutterstock.com

Dexcel Pharma, an Israel-based company, has sought a declaration of non-infringement against four Takeda patents.


Dexcel, Takeda, non-infringement, lansoprazole, FDA, NDA, patent

LSIPR